Previous 10 | Next 10 |
2023-09-06 13:47:07 ET More on Abbott, DexCom, etc. Compare metrics for ABT to DXCM, MDT, SENS Medtronic: The Crossroads Of Its Growth Trajectory Medtronic: The Tide Is Turning Medtronic: Dark Clouds Are Clearing - Outperformance Ahead Senseonics Face...
2023-09-06 13:21:07 ET Analysis of Penny Stocks with Insider Moves The allure of penny stocks is undeniable. Their low price point, combined with the potential for high returns, makes them a tantalizing option for investors. However, as with all investments, there are risks involved...
Toronto, Ontario--(Newsfile Corp. - August 14, 2023) - Sensor Technologies Corp. (CSE: SENS) (the "Company" or "Sensor") announces that Ms. Maria Diaz has resigned as a director of Sensor. The Company would like to wish Ms. Diaz success in her future endeavors. Mr. Brian Grieve has been appointe...
2023-08-10 18:29:08 ET Senseonics Holdings, Inc. (SENS) Q2 2023 Earnings Conference Call August 10, 2023, 04:30 PM ET Company Participants Philip Taylor - IR Tim Goodnow - President and CEO Rick Sullivan - CFO Conference Call Participants Colin Clark ...
2023-08-10 17:21:35 ET Shares of Senseonics ( NYSE: SENS ) on Thursday fell more than 6% in extended trading, after the medical device company swung to a quarterly loss and missed on revenue expectations. SENS stock retreated 6.4% to $0.69 after hours. The maker of i...
2023-08-10 16:16:09 ET Senseonics press release ( NYSE: SENS ): Q2 GAAP EPS of -$0.04 in-line. Revenue of $4.13M (+11.6% Y/Y) misses by $0.36M . U.S. revenue was $1.8 million in the second quarter of 2023 compared to $1.2 million in the prior year period, and ...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended June 30, 2023. Re...
2023-08-01 15:25:34 ET Summary Senseonics is a medtech firm specializing in long-term, implantable glucose monitoring technology for the diabetes community. Recent updates include UnitedHealthcare beginning coverage of Senseonics' Eversense E3 glucose monitor, potentially reaching...
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2023 financial res...
2023-07-26 12:28:48 ET The Appeal of High-Volatility Penny Stocks Today’s penny stock market is brimming with high-volatility stocks. That especially relates to those that fall into the category of the cheapest penny stocks . These inexpensive stocks, attractively low compare...
News, Short Squeeze, Breakout and More Instantly...
Senseonics Holdings Inc. Company Name:
SENS Stock Symbol:
NYSE Market:
Senseonics Holdings Inc. Website:
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2024 financial res...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced business updates and provided its full year 2024 financial out...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a business update and analyst event during the A...